3,225
+0.78%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Kukje Pharma Co
Its shares trade on KRX under the ticker 002720.KS. It has been listed since 27 December 1975. In the fiscal year to 31 December 2025, it reported revenue of ₩175.50bn and net income of ₩5.70bn. At that date it held total assets of ₩182.28bn and shareholders' equity of ₩97.69bn.
KUKJE PHARMA Co. Ltd. engages in the manufacture, sale, and distribution of pharmaceutical, cosmetics, and healthcare products. The company is headquartered in Seongnam, Gyeonggi-Do. Co., Ltd, is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company’s products are finished products, such as antibiotics, other antibiotics for injection, antifungal and antiviral agents, agents for gastrointestinal tract and liver, muscle relaxants, anti-osteoporotics, corticosteroids, agents for cardiovascular and endocrine systems, ophthalmic agents, remedies for central nervous system (CNS) disorders, remedies for urinary systems, antihistamines, antitussives, cough and cold remedies, non-steroidal anti inflammatory drugs (NSAIDs), antitussive, cough and cold remedies, as well as other over-the-counter (OTC) drugs. The company also provides raw materials, such as ceftriaxone sodium sterile, cefuroxime axetil, ceftezole sodium sterile, cefminox sodium sterile, cefuroxime sodium sterile and others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 27 Dec 1975
- Website
- kukjepharm.co.kr ↗
Leadership
Pay as last reported
- Mr. Yeong Wu NamHonorary Chairman, Co-Chief Executive Officer, since 2015
- Mr. Tae Hun NamPresident, Co-Chief Executive Officer, Director, since 2012
- Mr. Seong Gyu KimChief Operating Officer, Managing Director, since 2019
- Mr. Yeong Gwan KimManaging Director, Director
- Mr. Pil Seong ChoiNon-Executive Independent Director
- Mr. Jeong Su JeonNon-Executive Independent Director
- Mr. Ga Won LeeNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Kukje Pharma Co Ltd manufactures and distributes pharmaceutical products including antibiotics and antiviral agents in South Korea.
- The company's headquarters in Seongnam, Gyeonggi-Do, supports its operations within the Health Care sector.
- Kukje Pharma's product portfolio includes finished products such as corticosteroids and cardiovascular agents for the South Korean market.
Weaknesses
- Kukje Pharma Co Ltd has only one product line for raw materials, including ceftriaxone sodium sterile.
- The company's IPO in December 1975 indicates a long-standing presence but limited recent market activity.
- Kukje Pharma operates solely within South Korea, restricting its international market reach.
Opportunities
- Expanding into the global pharmaceutical market could leverage Kukje Pharma's existing product lines.
- The company can explore new markets for its OTC drugs, such as antihistamines and cough remedies.
- Kukje Pharma may develop additional raw material products to diversify its offerings.
Threats
- Competition from other South Korean pharmaceutical companies poses a threat to Kukje Pharma's market share.
- Regulatory changes in the South Korean Health Care sector could impact the company's operations.
- The reliance on a single country for sales may increase vulnerability to local economic fluctuations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.